Skip to main content

Thrombolytic therapy for myocardial infarction: a perspective of clinical trialists. The GUSTO Investigators.

Publication ,  Journal Article
Califf, RM; Topol, EJ
Published in: Clin Cardiol
March 1992

Duke Scholars

Published In

Clin Cardiol

DOI

ISSN

0160-9289

Publication Date

March 1992

Volume

15

Issue

3

Start / End Page

143 / 144

Location

United States

Related Subject Headings

  • Tissue Plasminogen Activator
  • Thrombolytic Therapy
  • Streptokinase
  • Myocardial Infarction
  • Humans
  • Heparin
  • Clinical Trials as Topic
  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Califf, R. M., & Topol, E. J. (1992). Thrombolytic therapy for myocardial infarction: a perspective of clinical trialists. The GUSTO Investigators. Clin Cardiol, 15(3), 143–144. https://doi.org/10.1002/clc.4960150303
Califf, R. M., and E. J. Topol. “Thrombolytic therapy for myocardial infarction: a perspective of clinical trialists. The GUSTO Investigators.Clin Cardiol 15, no. 3 (March 1992): 143–44. https://doi.org/10.1002/clc.4960150303.
Califf, R. M., and E. J. Topol. “Thrombolytic therapy for myocardial infarction: a perspective of clinical trialists. The GUSTO Investigators.Clin Cardiol, vol. 15, no. 3, Mar. 1992, pp. 143–44. Pubmed, doi:10.1002/clc.4960150303.

Published In

Clin Cardiol

DOI

ISSN

0160-9289

Publication Date

March 1992

Volume

15

Issue

3

Start / End Page

143 / 144

Location

United States

Related Subject Headings

  • Tissue Plasminogen Activator
  • Thrombolytic Therapy
  • Streptokinase
  • Myocardial Infarction
  • Humans
  • Heparin
  • Clinical Trials as Topic
  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology